232 related articles for article (PubMed ID: 13397426)
1. Metabolic studies with the arylsulfonylureas.
KUHL WJ
Diabetes; 1957; 6(1):61; discussion, 62. PubMed ID: 13397426
[No Abstract] [Full Text] [Related]
2. Metabolic studies with the arylsulfonylureas.
KUHL WJ
Metabolism; 1956 Nov; 5(6 Part 2):953-63. PubMed ID: 13378065
[No Abstract] [Full Text] [Related]
3. The arylsulfonylureas and diabetes mellitus.
LLOYD CW
J Clin Endocrinol Metab; 1956 Dec; 16(12):1626-8. PubMed ID: 13385311
[No Abstract] [Full Text] [Related]
4. Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus.
ERK V; HAAR H; MCGAVACK TH; SEEGERS W
Metabolism; 1956 Nov; 5(6 Part 2):919-32. PubMed ID: 13378061
[No Abstract] [Full Text] [Related]
5. The mechanism of action of the sulfonylureas in diabetes mellitus.
LEVINE R; SOBEL GW
Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633
[No Abstract] [Full Text] [Related]
6. Tolbutamide in treatment of diabetes mellitus.
BUTTERFIELD WJ; FRY IK; HARDWICK C; HOLLING HE
Br Med J; 1957 Aug; 2(5040):325-7. PubMed ID: 13446469
[No Abstract] [Full Text] [Related]
7. Tolbutamide in diabetes; some clinical and biochemical studies.
CROWLEY MF; WOLFF FW; BLOOM A
Br Med J; 1957 Aug; 2(5040):327-31. PubMed ID: 13446470
[No Abstract] [Full Text] [Related]
8. Current status of aryl sulfonylureas in treatment of diabetes mellitus.
DAVIDSON JW; UNGER RH
J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329
[No Abstract] [Full Text] [Related]
9. New orally effective adjuvants in the management of diabetes mellitus.
O'DONOVAN CJ
J Chronic Dis; 1956 Dec; 4(6):635-43. PubMed ID: 13376693
[No Abstract] [Full Text] [Related]
10. Clinical experience with tolbutamide.
WALKER G; SLATER JD; WESTLAKE EK; NABARRO JD
Br Med J; 1957 Aug; 2(5040):323-5. PubMed ID: 13446468
[No Abstract] [Full Text] [Related]
11. Sulfonylureas and diabetes mellitus. I. Clinical evaluation.
COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH
Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475
[No Abstract] [Full Text] [Related]
12. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference.
KRAHL ME; LUKENS FD; RICKETTS HT
Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436
[No Abstract] [Full Text] [Related]
13. Clinical experience and experimental studies with tolbutamide.
CRAIG JW; MILLER M
Diabetes; 1957; 6(3):280-2; discussion, 282-9. PubMed ID: 13427636
[No Abstract] [Full Text] [Related]
14. The hypoglucemic sulfonylurea drugs; an interim evaluation.
STETTEN D
Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912
[No Abstract] [Full Text] [Related]
15. BZ 55 in diabetes.
MCKENZIE JM; MARSHALL PB; STOWERS JM; HUNTER RB
Br Med J; 1956 Aug; 2(4990):448-51. PubMed ID: 13342510
[No Abstract] [Full Text] [Related]
16. Clinical use of oral sulfonylurea compounds in diabetes mellitus.
COLWELL AR; COLWELL JA
Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644
[No Abstract] [Full Text] [Related]
17. The value of BZ 55 in control of diabetes.
MURRAY I; WANG I
Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512
[No Abstract] [Full Text] [Related]
18. BZ 55 and D 860 in the treatment of diabetes mellitus.
SCHNEIDER T; POLITZER WM
S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061
[No Abstract] [Full Text] [Related]
19. Studies of the mechanism of action of sulfonylurea derivatives.
GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
[No Abstract] [Full Text] [Related]
20. CARBUTAMIDE and tolbutamide in diabetes.
S Afr Med J; 1956 Dec; 30(51):1221-2. PubMed ID: 13391101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
